• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重指数对根治性前列腺切除术后前列腺癌患者肿瘤学结局的影响。

Impact of Body Mass Index on Oncological Outcomes of Prostate Cancer Patients after Radical Prostatectomy.

机构信息

Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea.

Department of Urology, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Sci Rep. 2018 Aug 10;8(1):11962. doi: 10.1038/s41598-018-30473-y.

DOI:10.1038/s41598-018-30473-y
PMID:30097640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6086909/
Abstract

Obesity, often represented by higher body mass index (BMI), is not yet fully understood as a potential risk factor for poor clinical outcomes of prostate cancer (PCa) after radical prostatectomy (RP). This study aimed to evaluate the relationship between BMI and biochemical recurrence (BCR)-free survival in RP patients. This study retrospectively reviewed a total of 2.997 PCa patients who underwent RP between 2006 and 2017. The patients were stratified into three BMI groups according to the WHO recommendations for Asian men: normal weight (<23 kg/m), overweight (≥23 to <27.5 kg/m) and obese (≥27.5 kg/m). Multivariable logistic regression analyses were undertaken to evaluate the factors influencing the BCR rates including BMI. Multivariable Cox regression analyses and Kaplan-Meier analyses were performed to test the association of obesity with BCR-free survival. The final pathologic results showed obese patients had greater positive surgical margin rates (13.9%, p < 0.001), extraprostatic invasion (19.9%, p < 0.001), advanced pathological Gleason score (GS) ≥ 8 (50.8%, p = 0.017), and lymph node invasion (LNI) (14.5%, p = 0.021) than overweight and normal weight patients. According to Kaplan-Meier analyses, obese patients, especially with BMI ≥ 27.5, were more likely to have lower BCR-free-survival. Multivariate Cox analysis revealed that diabetes mellitus, LNI status, pT, pathologic GS, extraprostatic invasion, margin positivity and obesity with BMI ≥ 27.5 kg/m were significantly associated with BCR-free survival after RP. Obesity (higher BMI) was significantly associated with BCR after RP. BMI ≥ 27.5 kg/m was an independent predictor of BCR-free survival.

摘要

肥胖通常表现为更高的身体质量指数(BMI),但它是否是前列腺癌(PCa)根治性前列腺切除术后(RP)临床结局不良的潜在危险因素尚未得到充分认识。本研究旨在评估 BMI 与 RP 患者生化复发(BCR)无复发生存率之间的关系。本研究回顾性分析了 2006 年至 2017 年间接受 RP 的 2997 例 PCa 患者。根据世界卫生组织(WHO)对亚洲男性的建议,患者被分为三组 BMI:正常体重(<23kg/m)、超重(≥23 至<27.5kg/m)和肥胖(≥27.5kg/m)。采用多变量逻辑回归分析评估包括 BMI 在内的影响 BCR 率的因素。采用多变量 Cox 回归分析和 Kaplan-Meier 分析检验肥胖与 BCR 无复发生存之间的关系。最终的病理结果显示肥胖患者的阳性切缘率更高(13.9%,p<0.001),前列腺外侵犯(19.9%,p<0.001),高级别病理 Gleason 评分(GS)≥8(50.8%,p=0.017)和淋巴结侵犯(LNI)(14.5%,p=0.021)比超重和正常体重患者更常见。根据 Kaplan-Meier 分析,肥胖患者,尤其是 BMI≥27.5 的患者,更有可能出现较低的 BCR 无复发生存率。多变量 Cox 分析显示,糖尿病、LNI 状态、pT、病理 GS、前列腺外侵犯、切缘阳性和 BMI≥27.5kg/m 的肥胖与 RP 后 BCR 无复发生存显著相关。肥胖(更高的 BMI)与 RP 后 BCR 显著相关。BMI≥27.5kg/m 是 BCR 无复发生存的独立预测因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51c4/6086909/f44f6dc48f88/41598_2018_30473_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51c4/6086909/d21ce161b7ee/41598_2018_30473_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51c4/6086909/6d7db8635f5c/41598_2018_30473_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51c4/6086909/f44f6dc48f88/41598_2018_30473_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51c4/6086909/d21ce161b7ee/41598_2018_30473_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51c4/6086909/6d7db8635f5c/41598_2018_30473_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51c4/6086909/f44f6dc48f88/41598_2018_30473_Fig3_HTML.jpg

相似文献

1
Impact of Body Mass Index on Oncological Outcomes of Prostate Cancer Patients after Radical Prostatectomy.体重指数对根治性前列腺切除术后前列腺癌患者肿瘤学结局的影响。
Sci Rep. 2018 Aug 10;8(1):11962. doi: 10.1038/s41598-018-30473-y.
2
Low body mass index is associated with adverse oncological outcomes following radical prostatectomy in Korean prostate cancer patients.低体重指数与韩国前列腺癌患者根治性前列腺切除术后不良肿瘤学结局相关。
Int Urol Nephrol. 2014 Oct;46(10):1935-40. doi: 10.1007/s11255-014-0729-7. Epub 2014 May 10.
3
Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression.根治性前列腺切除术可消除肥胖驱动的前列腺癌进展风险。
Urol Oncol. 2017 May;35(5):243-249. doi: 10.1016/j.urolonc.2016.12.014. Epub 2017 Feb 1.
4
Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study.肥胖与前列腺癌根治术后生化复发相关:一项多机构扩展验证研究。
Urol Oncol. 2017 Jul;35(7):460.e1-460.e8. doi: 10.1016/j.urolonc.2017.01.022. Epub 2017 Apr 29.
5
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.根治性前列腺切除术是治疗标本中存在高病理 Gleason 评分前列腺癌的有效方法。
BJU Int. 2013 May;111(5):723-30. doi: 10.1111/j.1464-410X.2012.11114.x. Epub 2012 Apr 4.
6
Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.对于接受根治性前列腺切除术和扩大盆腔淋巴结清扫术的临床局限性前列腺癌患者,肥胖并不会增加淋巴结转移的风险。
Int J Urol. 2009 Aug;16(8):676-81. doi: 10.1111/j.1442-2042.2009.02330.x. Epub 2009 Jul 8.
7
The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.根治性前列腺切除术后前列腺特异性抗原持续存在对预测淋巴结阳性前列腺癌患者临床进展和癌症特异性死亡率的作用。
Eur Urol. 2016 Jun;69(6):1142-8. doi: 10.1016/j.eururo.2015.12.010. Epub 2015 Dec 31.
8
Obesity and long-term survival after radical prostatectomy.肥胖与根治性前列腺切除术的长期生存
J Urol. 2014 Oct;192(4):1100-4. doi: 10.1016/j.juro.2014.04.086. Epub 2014 Apr 21.
9
Short (≤ 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy.短(≤1 毫米)阳性切缘与根治性前列腺切除术后生化复发的风险。
BJU Int. 2013 Apr;111(4):559-63. doi: 10.1111/j.1464-410X.2012.11340.x. Epub 2012 Jul 3.
10
Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy.体重指数作为荷兰接受根治性前列腺切除术男性生化复发的预后标志物。
BJU Int. 2009 Aug;104(3):321-5. doi: 10.1111/j.1464-410X.2009.08404.x. Epub 2009 Feb 11.

引用本文的文献

1
Normal Weight, Overweight and Obesity Conditions Associated to Prostate Neoplasm Stages-A Systematic Review and Meta-Analysis.与前列腺肿瘤分期相关的正常体重、超重和肥胖状况——一项系统评价与荟萃分析
Biomedicines. 2025 May 13;13(5):1182. doi: 10.3390/biomedicines13051182.
2
Are Diabetic Patients at Increased Risk for Biochemical Recurrence After Radical Prostatectomy?糖尿病患者在根治性前列腺切除术后生化复发风险会增加吗?
Cureus. 2022 May 4;14(5):e24717. doi: 10.7759/cureus.24717. eCollection 2022 May.
3
Oxidative stress and redox signaling in CRPC progression: therapeutic potential of clinically-tested Nrf2-activators.

本文引用的文献

1
Are the Pathological Characteristics of Prostate Cancer More Aggressive or More Indolent Depending upon the Patient Age?前列腺癌的病理特征会因患者年龄而异,是更具侵袭性还是更惰性呢?
Biomed Res Int. 2017;2017:1438027. doi: 10.1155/2017/1438027. Epub 2017 Feb 7.
2
The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer.体重指数对低中危前列腺癌患者治疗结果的影响。
BMC Cancer. 2016 Jul 29;16:557. doi: 10.1186/s12885-016-2572-y.
3
Visceral adipose tissue measured by computed tomography and high-grade prostate cancer after radical prostatectomy.
去势抵抗性前列腺癌进展中的氧化应激与氧化还原信号传导:经临床测试的Nrf2激活剂的治疗潜力
Cancer Drug Resist. 2021 Mar 19;4(1):96-124. doi: 10.20517/cdr.2020.71. eCollection 2021.
4
Patients with Positive Lymph Nodes after Radical Prostatectomy and Pelvic Lymphadenectomy-Do We Know the Proper Way of Management?根治性前列腺切除术和盆腔淋巴结清扫术后淋巴结阳性的患者——我们知道正确的处理方法吗?
Cancers (Basel). 2022 May 8;14(9):2326. doi: 10.3390/cancers14092326.
5
Obesity and biochemical recurrence in clinically localised prostate cancer: a systematic review and meta-analysis of 86,490 patients.肥胖与局限性前列腺癌的生化复发:86490 例患者的系统评价和荟萃分析。
Prostate Cancer Prostatic Dis. 2022 Sep;25(3):411-421. doi: 10.1038/s41391-021-00481-7. Epub 2022 Jan 6.
6
Prediction of a positive surgical margin and biochemical recurrence after robot-assisted radical prostatectomy.机器人辅助根治性前列腺切除术术后切缘阳性和生化复发的预测。
Sci Rep. 2021 Jul 12;11(1):14329. doi: 10.1038/s41598-021-93860-y.
7
Overcoming Disparities in Cancer: A Need for Meaningful Reform for Hispanic and Latino Cancer Survivors.克服癌症差异:西班牙裔和拉丁裔癌症幸存者需要有意义的改革。
Oncologist. 2021 Jun;26(6):443-452. doi: 10.1002/onco.13729. Epub 2021 Mar 10.
8
Effect of obesity on the prognosis and recurrence of prostate cancer after radical prostatectomy: a meta-analysis.肥胖对前列腺癌根治术后预后及复发的影响:一项荟萃分析
Transl Androl Urol. 2020 Dec;9(6):2713-2722. doi: 10.21037/tau-20-1352.
9
The impact of robotic colorectal surgery in obese patients: a systematic review, meta-analysis, and meta-regression.机器人结直肠手术治疗肥胖患者的影响:系统评价、荟萃分析和荟萃回归。
Surg Endosc. 2019 Nov;33(11):3558-3566. doi: 10.1007/s00464-019-07000-9. Epub 2019 Jul 25.
通过计算机断层扫描测量的内脏脂肪组织与前列腺癌根治术后的高级别前列腺癌
Int J Obes (Lond). 2015 Nov;39(11):1659-61. doi: 10.1038/ijo.2015.111. Epub 2015 Jun 23.
4
Impact of obesity on outcomes after definitive dose-escalated intensity-modulated radiotherapy for localized prostate cancer.肥胖对局限性前列腺癌确定性剂量递增调强放疗后结局的影响。
Cancer. 2015 Sep 1;121(17):3010-7. doi: 10.1002/cncr.29472. Epub 2015 May 29.
5
Prostate cancer detection: The impact of obesity on Asian men.前列腺癌检测:肥胖对亚洲男性的影响。
Urol Oncol. 2015 Jun;33(6):266.e17-22. doi: 10.1016/j.urolonc.2015.03.011. Epub 2015 Apr 10.
6
The impact of obesity on prostate cancer recurrence observed after exclusion of diabetics.排除糖尿病患者后观察到肥胖对前列腺癌复发的影响。
Cancer Causes Control. 2015 Jun;26(6):821-30. doi: 10.1007/s10552-015-0554-z. Epub 2015 Mar 14.
7
American Society of Clinical Oncology position statement on obesity and cancer.美国临床肿瘤学会关于肥胖与癌症的立场声明。
J Clin Oncol. 2014 Nov 1;32(31):3568-74. doi: 10.1200/JCO.2014.58.4680. Epub 2014 Oct 1.
8
Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study.肥胖增加高级别前列腺癌风险:REDUCE研究结果
Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2936-42. doi: 10.1158/1055-9965.EPI-14-0795. Epub 2014 Sep 27.
9
Obesity and long-term survival after radical prostatectomy.肥胖与根治性前列腺切除术的长期生存
J Urol. 2014 Oct;192(4):1100-4. doi: 10.1016/j.juro.2014.04.086. Epub 2014 Apr 21.
10
Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy.肥胖与根治性前列腺切除术后侵袭性病理特征或生化复发无关。
Urology. 2013 May;81(5):992-6. doi: 10.1016/j.urology.2012.10.080. Epub 2013 Feb 28.